EN | ΕΛ
Browse Helios by "Author"
Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page
Showing results 1 to 9 of 9

DateTitleAuthor(s)Full text
2000Structural comparison between type I and type II antagonists: Possible implications in the drug design of AT1 antagonistsRoumelioti, P.; Tselios, T.; Alexopoulos, K.; Mavromoustakos, Thomas; Kolocouris, A.; Moore, G. J.; Matsoukas, J. M.
2000The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin IIMatsoukas, J. M.; Polevaya, L.; Ancans, J.; Mavromoustakos, Thomas; Kolocouris, A.; Roumelioti, P.; Vlahakos, D. V.; Yamdagni, R.; Wu, Q.; Moore, G. J.
1999Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: Importance of the Ala(81) carboxyl group and of at cyclic conformation for induction of experimental allergic encephalomyelitisTselios, T.; Probert, L.; Daliani, I.; Matsoukas, E.; Troganis, A.; Gerothanassis, I. P.; Mavromoustakos, Thomas; Moore, G. J.; Matsoukas, J. M.
1997Use of molecular modeling to study superimposition of the thrombin receptor motif S42FLLR46 with its peptidomimetic analogsMavromoustakos, Thomas; Theodoropoulou, E.; Alexopoulos, K.; Matsoukas, J.; Hollenberg, M.; Moore, G. J.
1997Conformational analysis of the thrombin receptor agonist peptides SFLLR and SFLLR-NH2 by NMR: Evidence for a cyclic bioactive conformationMatsoukas, J.; Hollenberg, M. D.; Mavromoustakos, Thomas; Panagiotopoulos, D.; Alexopulos, K.; Yamdagni, R.; Wu, Q.; Moore, G. J.
1997Structure elucidation and conformational analysis of gonadotropin releasing hormone and its novel synthetic analogue [Tyr(OMe)5, D-LyS6, Aze9NHEt]GnRH: The importance of aromatic clustering in the receptor binding activityMatsoukas, J. M.; Keramida, M.; Panagiotopoulos, D.; Mavromoustakos, Thomas; Maia, H. L. S.; Bigam, G.; Pati, D.; Habibi, H. R.; Moore, G. J.
1996Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: Importance of the Phe/Arg relative conformation and the primary amino group for activityMatsoukas, J. M.; Panagiotopoulos, D.; Keramida, M.; Mavromoustakos, Thomas; Yamdagni, R.; Wu, Q.; Moore, G. J.; Saifeddine, M.; Hollenberg, M. D.
1995Differences in Backbone Structure between Angiotensin-Ii Agonists and Type-I AntagonistsMatsoukas, J. M.; Agelis, G.; Wahhab, A.; Hondrelis, J.; Panagiotopoulos, D.; Yamdagni, R.; Wu, Q.; Mavromoustakos, Thomas; Maia, H. L. S.; Ganter, R.; Moore, G. J.
1994Role of the Nh2-Terminal Domain of Angiotensin-Ii (Ang-Ii) and [Sar(1)]Angiotensin-Ii on Conformation and Activity - Nmr Evidence for Aromatic Ring Clustering and Peptide Backbone Folding Compared with [Des-1,2,3]Angiotensin-IiMatsoukas, J. M.; Hondrelis, J.; Keramida, M.; Mavromoustakos, Thomas; Makriyannis, A.; Yamdagni, R.; Wu, Q.; Moore, G. J.
Showing results 1 to 9 of 9



 

Follow EKT at: